---
title: 'Clinical impact of panel gene sequencing on therapy of advanced cancers of
  the digestive system: a retrospective, single center study'
date: '2024-04-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38664720/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240426181346&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Actionable genetic alterations are frequently detected
  by panel gene sequencing in patients with advanced cancers of the digestive tract,
  providing clinical benefit in selected cases. However, for the majority of identified
  actionable alterations, sufficient clinical evidence for targeted treatments is
  still ...'
disable_comments: true
---
CONCLUSIONS: Actionable genetic alterations are frequently detected by panel gene sequencing in patients with advanced cancers of the digestive tract, providing clinical benefit in selected cases. However, for the majority of identified actionable alterations, sufficient clinical evidence for targeted treatments is still ...